The velocity of antihypertensive effect of losartan/hydrochlorothiazide and angiotensin II receptor blocker

Journal of Hypertension

Volumn 30, Issue 7, 2012, Pages 1478-1486

  Metoki, Hirohito ^a   Ohkubo, Takayoshi ^a,b   Kikuya, Masahiro ^a   Asayama, Kei ^a   Inoue, Ryusuke ^c   Obara, Taku ^a   Hirose, Takuo ^a   Sato, Michihiro ^a   Hashimoto, Takanao ^a   Imai, Yutaka ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

angiotensin II receptor blockers; exponential decay function; home blood pressure measurements; losartan HCTZ combination; maximal effect; stabilization time

Indexed keywords

CANDESARTAN HEXETIL; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; LOSARTAN POTASSIUM; OLMESARTAN; TELMISARTAN; VALSARTAN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MAXIMUM PERMISSIBLE DOSE; MONOTHERAPY; PRIORITY JOURNAL; PULSE RATE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 84862775528     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328353f1fe     Document Type: Article

References (26)

1. Saruta T, Ogihara T, Matsuoka H, Suzuki H, Toki M, Hirayama Y, et al. Antihypertensive efficacy and safety of fixed-dose combination therapy with losartan plus hydrochlorothiazide in Japanese patients with essential hypertension. Hypertens Res 2007; 30:729-739. (Pubitemid 47517107)
2. MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, et al., Patel A, ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370:829-840.
3. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, et al., ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359:2417-2428.
4. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007; 120:713-719. (Pubitemid 47176510)
5. Imai Y, Ohkubo T, Hozawa A, Tsuji I, Matsubara M, Araki T, et al. Usefulness of home blood pressure measurements in assessing the effect of treatment in a single-blind placebo-controlled open trial. J Hypertens 2001; 19:179-185. (Pubitemid 32116267)
6. Imai Y, Otsuka K, Kawano Y, Shimada K, Hayashi H, Tochikubo O, et al. Japanese Society ofHypertension. Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res 2003; 26:771-782. (Pubitemid 37406944)
7. Mashima K, Nakatsu T, Murakami T, Kusachi S, Tominaga Y, Yamane S, et al. Exponential-exponential cosine fitting of blood pressure decay induced by a long-acting calcium blocker, amlodipine, using home blood pressure measurement. Clin Exp Hypertens 2003; 25:145-154. (Pubitemid 36438128)
8. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363:2022-2031. (Pubitemid 38781102)
9. Kojima M, Dohi Y, Ohashi M, Sato K, Kimura G. Crucial role of kidney function in resistance to antihypertensive therapy in patients with diabetes mellitus. J Hypertens 2010; 28:2323-2328.
10. Chonan K, Kikuya M, Araki T, Fujiwara T, Suzuki M, Michimata M, et al. Device for the self-measurement of blood pressure that can monitor blood pressure during sleep. Blood Press Monit 2001; 6:203-205. (Pubitemid 33116417)
11. Association for the Advancement of Medical Instrumentation. American National Standard for Eletronic or Automated Sphygmomanometers (ANS/AAMI S 10-1987) Washington, DC: Association for the Advancement of Medical Instrumentation; 1987.
12. Byyny RL. Losartan potassium lowers blood pressure measured by ambulatory blood pressure monitoring. J Hypertens 1995; Suppl 13: S29-S33.
13. Chrysant SG, Weber MA, Wang AC, Hinman DJ. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide. Am J Hypertens 2004; 17:252-259. (Pubitemid 38293331)
14. McGill JB, Reilly PA. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial. Clin Ther 2001; 23:833-850. (Pubitemid 32554566)
15. Kloner RA, Weinberger M, Pool JL, Chrysant SG, Prasad R, Harris SM, et al. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Am J Cardiol 2001; 87:727-731. (Pubitemid 32209086)
16. Pool JL, Glazer R, Chiang YT, Gatlin M. Dose-response efficacy of valsartan, a new angiotensin II receptor blocker. J Hum Hypertens 1999; 13:275-281. (Pubitemid 29187010)
17. Yasu M, Obara T, Hanazawa T, Ogasawara K, Katada S, Metoki H, et al. Rapidity of home blood pressure reduction by angiotensin II receptor blocker losartan. J Blood Press 2010; 17:145-150; (in Japanese).
18. Obara T, Yasu M, Hanazawa T, Ogasawara K, Katada S, Metoki H, et al. Rapidity of home blood pressure reduction by angiotensin II receptor blocker candesartan. Diagnosis Treatment 2010; 98:1039-1045; (in Japanese).
19. Obara T, Yasu M, Hanazawa T, Ogasawara K, Katada S, Metoki H, et al. Rapidity of home blood pressure reduction by angiotensin II receptor blocker olmesartan. Ther Res 2010; 17:569-575; (in Japanese).
20. Yasu M, Obara T, Hanazawa T, Ogasawara K, Katada S, Metoki H, et al. Rapidity of home blood pressure reduction by angiotensin II receptor blocker telmisartan. J Blood Press 2010; 17:445-449; (in Japanese).
21. Furburg CD, Psaty BM, Myer JM. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92:1326-1331.
22. Jackson G, Pierscianowski TA, Mahon W, Condon J. Inappropriate antihypertensive therapy in the elderly. Lancet 1976; 18:1317-1318.
23. Hosie J, Premner AD, Fell PJ, James GV, Saul PA, Taylor S. Side effects of dihydropyridine therapy: comparison of amlodipine and nifedipine retard. J Cardiovasc Pharmacol 1993; Suppl A:S9-S12.
24. National Interventino Cooperataive Study in Elderly Hypertensives Study Group. Randomized double blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. Hypertension 1999; 34:1129-1133.
25. Lijnen P, Fagard R, Staessen J, Amery A. Effect of chronic diuretic treatment on the plasma renin-angiotensin-aldosterone system in essential hypertension. Br J Clin Pharmacol 1981; 12:378-392.
26. Corrao G, Nicotra F, Parodi A, Zambon A, Heiman F, Merlino L, et al. Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice. Hypertension 2011; 58:566-572.